Alzheimer's disease (AD) is the most common cause of dementia in elderly people.
Research focused on identifying compounds that restore cognition and memory in AD …

Mounting evidence accumulated over the past few years indicates that the neurotransmitter
serotonin plays a significant role in cognition. As a drug target, serotonin receptors have …

Background: Alzheimer's disease is a neurodegenerative disease showing alterations in
classical neurotransmitters, above all in the hippocampus and prefrontal/temporal cortices …

Alzheimer's disease (AD) is the most common cause of dementia in elderly people. Because
of the lack of effective treatments for this illness, research focused on identifying compounds …

Alzheimer's disease (AD) is the most common cause of dementia with an increasing impact
on the aging society. Although generations of researchers tried to unravel the …

Alzheimer's disease (AD) is one of the major neurodegenerative diseases that deteriorates
cognitive functions and primarily affects associated brain regions involved in learning and …

Objective Selective serotonin reuptake inhibitors (SSRIs) have increased cognitive
performance in some clinical studies of Alzheimer's disease (AD), but it is has been difficult …

Despite the well-founded rationale for the use of cholinomimetic and monoaminergic agents
in the treatment of Alzheimer's disease, thus far, these strategies have only led to modest …

Introduction: Pharmacotherapy for the treatment of depressive disorders in Alzheimer's
Disease (AD) represents a clinical challenge. pharmacological options are often attempted …

Despite the better understanding of the mechanisms underlying Alzheimer's Disease (AD)
and launched clinical trials, no AD-modifying treatment based on a synthetic drug has been …